Fig. 2From: Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapyTGF-β pathway mutation and survival after recurrence in Non-MAC patients. Abbreviations: MAC, mucinous adenocarcinomaBack to article page